UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Merit Medical Systems
MMSI
$5.32B
| $431K | ﹤0.01% |
22,398
+4,800
| +27% | +$85.5K |
|
|
RATE
2002
DELISTED
Bankrate Inc
RATE
| $431K | ﹤0.01% |
37,998
+10,000
| +36% | +$124K |
|
|
EGOV
2003
DELISTED
NIC Inc
EGOV
| $430K | ﹤0.01% |
24,320
+1,100
| +5% | +$18.7K |
|
|
VRTU
2004
DELISTED
Virtusa Corporation
VRTU
| $430K | ﹤0.01% |
10,399
+600
| +6% | +$23.9K |
|
|
TBI
2005
Trueblue
TBI
$311M
| $429K | ﹤0.01% |
17,599
+900
| +5% | +$20.2K |
|
2006
Qualys
QLYS
$6.35B
| $428K | ﹤0.01% |
9,200
+400
| +5% | +$17.1K |
|
|
ALJ
2007
DELISTED
Alon USA Energy Inc
ALJ
| $427K | ﹤0.01% |
25,799
+1,000
| +4% | +$13.2K |
|
|
MDAS
2008
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $427K | ﹤0.01% |
22,698
+1,400
| +7% | +$26.6K |
|
|
MITT
2009
TPG Mortgage Investment Trust
MITT
$225M
| $426K | ﹤0.01% |
7,533
+500
| +7% | +$28K |
|
2010
Red Robin
RRGB
$152M
| $426K | ﹤0.01% |
4,900
+200
| +4% | +$16.2K |
|
|
ARNA
2011
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $426K | ﹤0.01% |
9,741
+460
| +5% | +$21.4K |
|
|
CSGS
2012
DELISTED
CSG Systems International
CSGS
| $425K | ﹤0.01% |
13,999
+600
| +4% | +$16.9K |
|
|
CCMP
2013
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $425K | ﹤0.01% |
8,500
+400
| +5% | +$19.7K |
|
2014
Encore Capital Group
ECPG
$2.13B
| $424K | ﹤0.01% |
10,199
+500
| +5% | +$20.8K |
|
2015
Harmony Gold Mining
HMY
$12.3B
| $422K | ﹤0.01% |
242,453
+131,609
| +119% | +$318K |
|
2016
CareTrust REIT
CTRE
$9.74B
| $421K | ﹤0.01% |
31,035
+4,800
| +18% | +$62K |
|
2017
Cato Corp
CATO
$66.1M
| $420K | ﹤0.01% |
10,599
+600
| +6% | +$25.5K |
|
|
CLD
2018
DELISTED
Cloud Peak Energy Inc
CLD
| $420K | ﹤0.01% |
72,083
+25,185
| +54% | +$186K |
|
2019
PENN Entertainment
PENN
$2.71B
| $418K | ﹤0.01% |
26,698
-18,900
| -41% | -$297K |
|
|
ELGX
2020
DELISTED
Endologix Inc
ELGX
| $418K | ﹤0.01% |
2,450
+140
| +6% | +$21.2K |
|
2021
Stride
LRN
$3.43B
| $417K | ﹤0.01% |
26,499
+700
| +3% | +$10.4K |
|
|
LTXB
2022
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $416K | ﹤0.01% |
18,299
+3,800
| +26% | +$85.4K |
|
2023
Aaon
AAON
$7.77B
| $415K | ﹤0.01% |
25,383
+750
| +3% | +$11.3K |
|
2024
Gray Television
GTN
$552M
| $415K | ﹤0.01% |
30,000
+1,300
| +5% | +$14.8K |
|
2025
Zumiez
ZUMZ
$339M
| $415K | ﹤0.01% |
10,299
+400
| +4% | +$15.5K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.